MOLECULAR SCREENING FOR HEPATITIS VIRUS

HBV can cause acute and chronic infection. There is currently no role for molecular testing in the diagnosis of acute hepatitis B other than in the detection of asymptomatic patients during pretransfusion screening of blood products. To facilitate an understanding of the utility of molecular testing for chronic hepatitis B, the four stages of chronic hepatitis B infection that are currently recognized, as well as an additional entity, occult hepatitis B, that can be diagnosed only by sensitive nucleic acid amplification methods, are reviewed in detail, including available therapeutic age.

 


  • Serological and molecular testing
  • Laboratory methods for Diagnosis & management
  • Current molecular metho

Related Conference of MOLECULAR SCREENING FOR HEPATITIS VIRUS

June 04-05, 2025

25th International Conference on Gastroenterology and Hepatology

Edinburgh, Scotland
July 07-08, 2025

20th Euro-Global Gastroenterology Conference

Zurich, Switzerland
July 28-29, 2025

31st World Conference on Gastroenterology & Hepatology

Dubai, UAE
July 30-31, 2025

16th International Conference on Liver Diseases & Hepatology

Aix-en-Provence, France
July 30-31, 2025

4th International Conference on Gastroenterology and Liver

Paris, France
August 21-22, 2025

6th Global Summit on Earth Science and Climate Change

Paris, France
August 21-22, 2025

17th World Conference on Gynecology, Obstetrics and Women Health

London, UK
August 27-28, 2025

13th World Gastro Summit

Paris, France
September 29-30, 2025

7th International Conference on Gastroenterology and Liver Diseases

Paris, France
October 20-21, 2025

24th International Conference on Gastroenterology and Digestive Disorders

Osaka, Japan

MOLECULAR SCREENING FOR HEPATITIS VIRUS Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in